Aveo Oncology
Aveo backs off on tivozanib approval after FDA calls for more conclusive data
November 6, 2019Research and Development, Sales and Marketing Aveo Oncology, FDA, pharma
Aveo Oncology has hit another hurdle in its quest for approval of its vascular endothelial growth factor receptor tyrosine kinase …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
